Skip to main content

Table 3 Clinical, Hormonal and Echocardiographic variables (mean ± SD) in patients with Thyroid Dysfunction before and after treatment

From: Myocardial ultrasonic tissue characterization in patients with thyroid dysfunction

 

Hyperthyroidism

(n = 10)

Hypothyroidism

(n = 6)

Subclinical Hypothyroidism

(n = 8)

 

Baseline

Treatment

Baseline

Treatment

Baseline

Treatment

HR (min-1)

90.7 ± 23.5

80 ± 16.4

67.3 ± 11.1

69.7 ± 13.8

78.8 ± 14.3

78.3 ± 10.7

EF (%)

70.4 ± 5.6

71.7 ± 5.1

70.7 ± 4.7

71.0 ± 5.2

71.2 ± 5.4

72 ± 4.4

LVMI (g/m2)

72.2 ± 11.1

68.0 ± 11.5

82.0 ± 15.7

80.7 ± 16.0

70.8 ± 9.7

69.2 ± 10.2

LVd (cm)

4.9 ± 0.3

4.7 ± 0.3 a

4.9 ± 0.2

4.9 ± 0.2

4.8 ± 0.3

4.8 ± 0.3

TSH (mU/L)

0.009 ± 0.01

2.1 ± 1.4 b

141.2 ± 96.9

1.7 ± 1.5 a

10.6 ± 7.1

2.4 ± 1.3a

FT4 (ng/dl)

4.3 ± 1.6

1.2 ± 0.2 b

0.2 ± 0.08

1.53 ± 0.2a

1.0 ± 0.2

1.4 ± 0.3 a

FT3 (pg/ml)

13.5 ± 9.2

3.1 ± 0.9

-

-

-

-

  1. a = p < 0.05; b = p < 0.005 vs baseline
  2. HR = heart rate; EF = ejection fraction; LVMI = left ventricular mass index; LVd = left ventricular diastolic dimension; TSH = thyroid stimulator hormone; FT4 = free T4; FT3 = free T3